Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer.
Sho M, Akahori T, Tanaka T, Kinoshita S, Nagai M, Nishiwada S, Tamamoto T, Nishiofuku H, Ohbayashi C, Hasegawa M, Kichikawa K, Nakajima Y.
Sho M, et al. Among authors: ohbayashi c.
Langenbecks Arch Surg. 2015 May;400(4):477-85. doi: 10.1007/s00423-015-1304-0. Epub 2015 May 1.
Langenbecks Arch Surg. 2015.
PMID: 25929828